NCT01827384 2023-09-29MPACT Study to Compare Effects of Targeted Drugs on Tumor Gene VariationsNational Cancer Institute (NCI)Phase 2 Completed208 enrolled 27 charts
NCT01024946 2015-05-12Everolimus (RAD001) for the Treatment of Malignant Pleural Mesothelioma With Merlin/NF2 Loss as a Biomarker to Predict SensitivityMemorial Sloan Kettering Cancer CenterPhase 2 Completed11 enrolled 6 charts